Atossa Genetics (ATOS)
(Delayed Data from NSDQ)
$1.46 USD
0.00 (0.00%)
Updated May 24, 2024 04:00 PM ET
After-Market: $1.46 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Atossa Genetics Inc. [ATOS]
Reports for Purchase
Showing records 41 - 58 ( 58 total )
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
FDA meeting completed; new 510(k) in the works
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
We are suspending coverage in order to focus on other areas of interest to our institutional clients.
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Q2FY13 Results mixed but Company increases physician adoption of ForeCYTE
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
We are transferring coverage as a result of reorganization of our coverage universe
Provider: STONEGATE CAPITAL MARKETS
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Initiation of Coverage: ATOS: Priming the Pump for Diagnostic Breast Cancer Testing
Provider: STONEGATE CAPITAL MARKETS
Analyst: RODRIGUEZ M
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company received a Warning Letter from the FDA
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G